Hypoxic and pharmacological preconditioning preserves vasomotor response of porcine coronary artery

Polish Journal of Pharmacology

Volumn 56, Issue 6, 2004, Pages 789-797

  Kužner, Jernej ^a   Drevenšek, Gorazd ^a   Geršak, Borut ^a   Budihna, Metka ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Contraction; Porcine coronary artery; Preconditioning; Relaxation

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; ADENOSINE; ADRENALIN; ANGIOTENSIN; NITRIC OXIDE SYNTHASE; POTASSIUM CHLORIDE; PROSTAGLANDIN SYNTHASE; SUBSTANCE P;

ANALYSIS OF VARIANCE; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY OBSTRUCTION; HYPOXIA; ISOLATED ARTERY; NONHUMAN; REOXYGENATION; STATISTICAL SIGNIFICANCE; SWINE; VASOMOTOR REFLEX;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ACETYLCHOLINE; ADENOSINE; ANGIOTENSIN II; ANIMALS; CORONARY VESSELS; EPINEPHRINE; NITROARGININE; OXYGEN; SUBSTANCE P; SWINE; VASOCONSTRICTION; VASODILATION;

EID: 14244263020     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Cohen MV, Baines CP, Downey JM: Ischemic preconditioning: from adenosine receptor to KATP channel. Annu Rev Physiol, 2000, 62, 79-109.
2. Cohen MV, Yang XM, Liu GS, Heusch G, Downey JM: Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K(ATP) channels. Circ Res, 2001, 89, 273-278.
3. Drevenšek G, Kirbiš S, Bunc M, Žitko M, Budihna VM, Šuput D: Tezosentan inhibits both equinatoxin II- and endotelin-1-induced contractions of isolated porcine coronary artery in a similar way. J Nat Toxins, 2002, 11, 231-244.
4. Fukuda S, Sakuma K, Tsukui A, Fujiwara N, Tanaka T, Fujihara H, Toriumi T, Shimoji K: Hypoxia modifies the vasodilatory effects of nitroglycerin, prostaglandin E1, and hydralazine on isolated porcine coronary arteries. J Cardiovasc Pharmacol, 1994, 23, 852-858.
5. Garg S, Hofstra L, Reutelingsperger C, Narula J: Apoptosis as a therapeutic target in acutely ischemic myocardium. Curr Opin Cardiol, 2003, 18, 372-377.
6. Japelj I, Budihna MV, Stanovnik L, Krisch I: Stereoselective and endothelium-independent action of nicardipine on the isolated porcine coronary artery. Eur J Pharmacol, 1999, 369, 43-47.
7. Kaeffer N, Richard V, Thuillez C: Delayed coronary endothelial protection 24 hours after preconditioning: role of free radicals. Circulation, 1997, 96, 2311-2316.
8. Kloner RA, Jennings RB: Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 2. Circulation, 2002, 104, 3158-3167.
9. Kojda G, Klaus W, Werner G, Fricke U: Intervascular and stimulus selectivity of nitrendipine and related derivatives in KCl and prostaglandin F2 precontracted porcine arteries. Br J Pharmacol, 1992, 106, 85-90.
10. Kwan YW, Wadsworth RM, Kane KA: Hypoxia- and endothelium-mediated changes in the pharmacological responsiveness of circumflex coronary artery rings from the sheep. Br J Pharmacol, 1989, 96, 857-863.
11. Laude K, Beauchamp P, Thuillez C, Richard V: Endothelial protective effects of preconditioning. Cardiovasc Res, 2002, 55, 466-473.
12. Laude K, Thuillez C, Richard V: Coronary endothelial dysfunction after ischemia and reperfusion: a new therapeutic target. Braz J Med Biol Res, 2001, 34, 1-7.
13. MaassenVanDenBrink A, de Vries R, Saxena PR, Schalekamp MA, Danser AH: Vasoconstriction by in situ formed angiotensin II: role of ACE and chymase. Cardiovasc Res, 1999, 44, 407-415.
14. Mankad PS, Amrani M, Rothery S, Severs NJ, Yacoub MH: Relative susceptibility of endothelium and myocardial cells to ischaemia-reperfusion injury. Acta Physiol Scand, 1997, 161, 103-112.
15. Marrelli SP, Johnson TD, Khorovets A, Childres WF, Bryan RM Jr: Altered function of inward rectifier potassium channels in cerebrovascular smooth muscle after ischemia/reperfusion. Stroke, 1998, 29, 1469-1474.
16. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation, 1986, 74, 1124-1136.
17. Nakano A, Cohen MV, Downey JM: Ischemic preconditioning: from basic mechanisms to clinical applications. Pharmacol Ther, 2000, 86, 263-275.
18. Olanrewaju HA, Mustafa SJ: Adenosine A(2A) and A(2B) receptors mediated nitric oxide production in coronary artery endothelial cells. Gen Pharmacol, 2000, 35, 171-177.
19. Olanrewaju HA, Qin W, Feoktistov I, Scemama JL, Mustafa SJ: Adenosine A(2A) and A(2B) receptors in cultured human and porcine coronary artery endothelial cells. Am J Physiol Heart Circ Physiol, 2000, 279, H650-H656.
20. Ordonez Fernandez A, Hernandez Fernandez A, Borrego Dominguez JM, Gutierrez Carretero E, Munoz Garcia J, Prieto Rodriguez MF, Viloria Penas MM: Coronary vasomotor disorders during hypoxia-reoxygenation: do calcium channel blockers play a protective role? Res Exp Med (Berl), 2000, 199, 319-331.
21. Pagliaro P, Rastaldo R, Losano G, Gattullo D: Mitochondrial ATP-sensitive channel opener does not induce vascular preconditioning, but potentiates the effect of a preconditioning ischemia on coronary reactive hyperemia in the anesthetized goat. Pflügers Arch, 2001, 443, 166-174.
22. Ren Z, Yang Q, Floten HS, Furnary AP, Yim AP, He GW: ATP-sensitive potassium channel openers may mimic the effects of hypoxic preconditioning on the coronary artery. Ann Thorac Surg, 2001, 71, 642-647.
23. Rubino A, Yellon DM: Ischaemic preconditioning of the vasculature: an overlooked phenomenon for protecting the heart. Trends Pharmacol Sci, 2000, 21, 225-230.
24. Schulz R, Cohen MV, Behrends M, Downey JM, Heusch G: Signal transduction of ischemic preconditioning. Cardiovasc Res, 2001, 52, 181-198.
25. Schulz R, Post H, Vahlhaus C, Heusch G: Ischemic preconditioning in pigs: a graded phenomenon: its relation to adenosine and bradykinin. Circulation, 1998, 98, 1022-1029.
26. Sharma A, Singh M: Possible mechanism of cardioprotective effect of angiotensin preconditioning in isolated rat heart. Eur J Pharmacol, 2000, 406, 85-92.
27. Sommerschild HT, Kirkeboen KA: Adenosine and cardioprotection during ischaemia and reperfusion - an overview. Acta Anaesthesiol Scand, 2000, 44, 1038-1055.
28. Vedernikov YP, Graser T, Leisner H, Tiedt N: Effect of hypoxia on endothelium-dependent relaxation of porcine coronary arteries and veins. Biomed Biochim Acta, 1991, 50, 257-263.
29. Vedernikov YP, Graser T, Li DS: Hypoxic and posthypoxic responses in isolated coronary arteries and veins: role of endothelium. Biomed Biochim Acta, 1990, 49, 1177-1184.
30. Zhao H, Miller M, Pfeiffer K, Buras JA, Stahl GL: Anoxia and reoxygenation of human endothelial cells decrease ceramide glucosyltransferase expression and activate caspases. FASEB J, 2003, 17, 723-724.
31. Zhou X, Zhai X, Ashraf M. Preconditioning of bovine endothelial cells: the protective effect is mediated by an adenosine A2 receptor through a protein kinase C signaling pathway. Circ Res, 1996, 78, 73-81.